NORFLEXTM - Medsafe
NEW ZEALAND DATA SHEET NORFLEXTM NORFLEX Page 1 of 5 1 PRODUCT NAME NORFLEX 100 mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each …
Download NORFLEXTM - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Macrobid (nitrofurantoin monohydrate/macrocrystals) Capsules
macrobid.comThis ART is to show size, copy placement and color breaks. Actual colors will be matched on press to approved color standards and/or PMS color swatches.
LACTOSE MONOHYDRATE - uspbpep.com
uspbpep.comEUROPEAN PHARMACOPOEIA 5.0 Lactose monohydrate Bulkandtappeddensity(2.9.15).Determine the bulk density and the tapped density. Calculate the Hausner index using the following expression:
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4 Missed dose If a dose is missed, it should be taken within the same day as soon as the patient remembers. However, if the next scheduled dose is due within 8 …
Milk Allergy Avoidance List - Kids With Food Allergies
www.kidswithfoodallergies.orgMilk Allergy Avoidance List Hidden Names for Milk Compiled by Debra A. Indorato RD, LDN, member of KFA’s Medical Advisory Team Foods covered by the FDA labeling laws that contain milk must be labeled in plain English to declare that it “contains milk.”
CARVEDILOL 3.125 MG, 6.25 MG, 12.5 MG AND 25 MG …
www.mhra.gov.ukPAR Carvedilol 3.125 mg, 6.25 mg, 12.5 mg and 25 mg Tablets PL 33410/0004-7 6 for human consumption and prepared without the use of other ruminant materials, except calf